Patients, doctors await FDA decision on experimental Alzheimer's drug
Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer's disease.
Jan 6, 2023
0
30
Nutritional and Metabolic Diseases: News and Research on Cerebral Amyloid Angiopathy
MeSH tree: C18.452.845.500.100
Second death in trial of experimental Alzheimer's drug is raising concerns
Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer's drug, calling into question the medication's safety.
Nov 29, 2022
0
100
New therapeutic drug for Alzheimer's disease without inflammatory side effects
Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA approved drug for Alzheimer's disease (AD) based on its ability to decrease Aβ plaque burden in AD patients, its effect ...
Aug 4, 2022
0
97
